Neurocognitive impairment in the deficit subtype of schizophrenia

European Archives of Psychiatry and Clinical Neuroscience

Volumn 266, Issue 5, 2016, Pages 397-407

  Fervaha, Gagan ^a,b   Agid, Ofer ^a,b,c   Foussias, George ^a,b,c   Siddiqui, Ishraq ^a,b   Takeuchi, Hiroyoshi ^a,c   Remington, Gary ^a,b,c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Amotivation; Avolition apathy; Deficit syndrome; Neurocognition; Persistent negative symptoms; Psychotic disorder

Indexed keywords

PERPHENAZINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADULT; ALERTNESS; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTINUOUS PERFORMANCE TEST; CONTROLLED ORAL WORD ASSOCIATION TEST; CONTROLLED STUDY; DEPRESSION; DISCRIMINANT ANALYSIS; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FOLLOW UP; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; NEUROPSYCHOLOGICAL TEST; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; QUALITY OF LIFE; SCHIZOPHRENIA; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; VERBAL MEMORY; WECHSLER ADULT INTELLIGENCE SCALE; WISCONSIN CARD SORTING TEST; WORKING MEMORY; CLASSIFICATION; COGNITION DISORDERS; COMPLICATION; MIDDLE AGED; NONPARAMETRIC TEST; PSYCHOLOGY;

ADULT; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STATISTICS, NONPARAMETRIC;

EID: 84938853325     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-015-0629-6     Document Type: Article

References (61)

1. Heinrichs RW, Zakzanis KK (1998) Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12:426–445
2. Bobes J, Arango C, Garcia-Garcia M, Rejas J (2010) Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the clamors study. J Clin Psychiatry 71:280–286
3. Milev P, Ho BC, Arndt S, Andreasen NC (2005) Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry 162:495–506
4. Mohamed S, Rosenheck R, Swartz M, Stroup S, Lieberman JA, Keefe RS (2008) Relationship of cognition and psychopathology to functional impairment in schizophrenia. Am J Psychiatry 165:978–987
5. Fervaha G, Foussias G, Agid O, Remington G (2014) Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia. Acta Psychiatr Scand 130:290–299
6. Carpenter WT Jr, Heinrichs DW, Wagman AM (1988) Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 145:578–583
7. Kirkpatrick B, Buchanan RW, Ross DE, Carpenter WT Jr (2001) A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry 58:165–171
8. Galderisi S, Maj M (2009) Deficit schizophrenia: an overview of clinical, biological and treatment aspects. Eur Psychiatry 24:493–500
9. Kirkpatrick B, Galderisi S (2008) Deficit schizophrenia: an update. World Psychiatry 7:143–147
10. Wagman AM, Heinrichs DW, Carpenter WT Jr (1987) Deficit and nondeficit forms of schizophrenia: neuropsychological evaluation. Psychiatry Res 22:319–330
11. Buchanan RW, Strauss ME, Kirkpatrick B, Holstein C, Breier A, Carpenter WT Jr (1994) Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia. Arch Gen Psychiatry 51:804–811
12. Galderisi S, Maj M, Mucci A, Cassano GB, Invernizzi G, Rossi A, Vita A, Dell’Osso L, Daneluzzo E, Pini S (2002) Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study. Am J Psychiatry 159:983–990
13. Cohen AS, Saperstein AM, Gold JM, Kirkpatrick B, Carpenter WT Jr, Buchanan RW (2007) Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date. Schizophr Bull 33:1201–1212
14. Putnam KM, Harvey PD (2000) Cognitive impairment and enduring negative symptoms: a comparative study of geriatric and nongeriatric schizophrenia patients. Schizophr Bull 26:867–878
15. Rethelyi JM, Czobor P, Polgar P, Mersich B, Balint S, Jekkel E, Magyar K, Meszaros A, Fabian A, Bitter I (2012) General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia. Eur Arch Psychiatry Clin Neurosci 262:107–115
16. Ahmed AO, Strauss GP, Buchanan RW, Kirkpatrick B, Carpenter WT (2015) Are negative symptoms dimensional or categorical? Detection and validation of deficit schizophrenia with taxometric and latent variable mixture models. Schizophr Bull 41:879–891
17. Csukly G, Polgar P, Tombor L, Benkovits J, Rethelyi J (2014) Theory of mind impairments in patients with deficit schizophrenia. Compr Psychiatry 55:349–356
18. Pegoraro LF, Dantas CR, Banzato CE, Fuentes D (2013) Correlation between insight dimensions and cognitive functions in patients with deficit and nondeficit schizophrenia. Schizophr Res 147:91–94
19. Cascella NG, Testa SM, Meyer SM, Rao VA, Diaz-Asper CM, Pearlson GD, Schretlen DJ (2008) Neuropsychological impairment in deficit vs. non-deficit schizophrenia. J Psychiatr Res 42:930–937
20. Dickerson F, Kirkpatrick B, Boronow J, Stallings C, Origoni A, Yolken R (2006) Deficit schizophrenia: association with serum antibodies to cytomegalovirus. Schizophr Bull 32:396–400
21. Strauss GP, Allen DN, Duke LA, Ross SA, Schwartz J (2008) Automatic affective processing impairments in patients with deficit syndrome schizophrenia. Schizophr Res 102:76–87
22. Wang X, Yao S, Kirkpatrick B, Shi C, Yi J (2008) Psychopathology and neuropsychological impairments in deficit and nondeficit schizophrenia of chinese origin. Psychiatry Res 158:195–205
23. Polgar P, Farkas M, Nagy O, Kelemen O, Rethelyi J, Bitter I, Myers CE, Gluck MA, Keri S (2008) How to find the way out from four rooms? The learning of “chaining” associations may shed light on the neuropsychology of the deficit syndrome of schizophrenia. Schizophr Res 99:200–207
24. Dantas CR, Barros BR, Fernandes PT, Li LM, Banzato CE (2011) Insight controlled for cognition in deficit and nondeficit schizophrenia. Schizophr Res 128:124–126
25. Galderisi S, Bucci P, Mucci A, Kirkpatrick B, Pini S, Rossi A, Vita A, Maj M (2013) Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome. Schizophr Res 147:157–162
26. Beck AT, Grant PM, Huh GA, Perivoliotis D, Chang NA (2013) Dysfunctional attitudes and expectancies in deficit syndrome schizophrenia. Schizophr Bull 39:43–51
27. Chen C, Jiang W, Zhong N, Wu J, Jiang H, Du J, Li Y, Ma X, Zhao M, Hashimoto K, Gao C (2014) Impaired processing speed and attention in first-episode drug naive schizophrenia with deficit syndrome. Schizophr Res 159:478–484
28. Stroup TS, McEvoy JP, Swartz MS, Byerly MJ, Glick ID, Canive JM, McGee MF, Simpson GM, Stevens MC, Lieberman JA (2003) The national institute of mental health clinical antipsychotic trials of intervention effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr Bull 29:15–31
29. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353:1209–1223
30. First MB (1997) User’s guide for the structured clinical interview for DSM-IV AXIS I disorders SCID-I: Clinician version. Amer Psychiatric Pub Inc, Washington
31. Keefe RS, Mohs RC, Bilder RM, Harvey PD, Green MF, Meltzer HY, Gold JM, Sano M (2003) Neurocognitive assessment in the clinical antipsychotic trials of intervention effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale. Schizophr Bull 29:45–55
32. Keefe RS, Bilder RM, Harvey PD, Davis SM, Palmer BW, Gold JM, Meltzer HY, Green MF, Miller DD, Canive JM, Adler LW, Manschreck TC, Swartz M, Rosenheck R, Perkins DO, Walker TM, Stroup TS, McEvoy JP, Lieberman JA (2006) Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology 31:2033–2046
33. Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese FJ 3rd, Gold JM, Goldberg T, Heaton RK, Keefe RS, Kraemer H, Mesholam-Gately R, Seidman LJ, Stover E, Weinberger DR, Young AS, Zalcman S, Marder SR (2008) The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity. Am J Psychiatry 165:203–213
34. Kerr SL, Neale JM (1993) Emotion perception in schizophrenia: specific deficit or further evidence of generalized poor performance? J Abnorm Psychol 102:312–318
35. Green MF, Penn DL, Bentall R, Carpenter WT, Gaebel W, Gur RC, Kring AM, Park S, Silverstein SM, Heinssen R (2008) Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities. Schizophr Bull 34:1211–1220
36. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276
37. Addington D, Addington J, Schissel B (1990) A depression rating scale for schizophrenics. Schizophr Res 3:247–251
38. Addington D, Addington J, Maticka-Tyndale E (1994) Specificity of the calgary depression scale for schizophrenics. Schizophr Res 11:239–244
39. Collins AA, Remington G, Coulter K, Birkett K (1996) Depression in schizophrenia: a comparison of three measures. Schizophr Res 20:205–209
40. Simpson GM, Angus JW (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 212:11–19
41. Tracy K, Adler LA, Rotrosen J, Edson R, Lavori P (1997) Interrater reliability issues in multicenter trials, part I: theoretical concepts and operational procedures used in department of veterans affairs cooperative study #394. Psychopharmacol Bull 33:53–57
42. Heinrichs DW, Hanlon TE, Carpenter WT Jr (1984) The quality of life scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull 10:388–398
43. Harvey PD, Raykov T, Twamley EW, Vella L, Heaton RK, Patterson TL (2011) Validating the measurement of real-world functional outcomes: phase I results of the VALERO study. Am J Psychiatry 168:1195–1201
44. Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT Jr (1989) The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res 30:119–123
45. Mueser KT, Douglas MS, Bellack AS, Morrison RL (1991) Assessment of enduring deficit and negative symptom subtypes in schizophrenia. Schizophr Bull 17:565–582
46. Addington D, Addington J, Maticka-Tyndale E (1993) Assessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry 163:39–44
47. Kirkpatrick B, Buchanan RW, Breier A, Carpenter WT Jr (1993) Case identification and stability of the deficit syndrome of schizophrenia. Psychiatry Res 47:47–56
48. Strauss GP, Horan WP, Kirkpatrick B, Fischer BA, Keller WR, Miski P, Buchanan RW, Green MF, Carpenter WT Jr (2013) Deconstructing negative symptoms of schizophrenia: avolition–apathy and diminished expression clusters predict clinical presentation and functional outcome. J Psychiatr Res 47:783–790
49. Cohen J (1988) Statistical power analysis for the behavioral sciences. Adademic Press, New York
50. Fervaha G, Zakzanis KK, Foussias G, Graff-Guerrero A, Agid O, Remington G (2014) Motivational deficits and cognitive test performance in schizophrenia. JAMA Psychiatry 71:1058–1065
51. Gur RC, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Gur RE (2014) Neurocognitive performance in family-based and case–control studies of schizophrenia. Schizophr Res 163:17–23
52. Ventura J, Hellemann GS, Thames AD, Koellner V, Nuechterlein KH (2009) Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis. Schizophr Res 113:189–199
53. Dantas CR, Barros BR, Banzato CE, Fernandes PT, Li LM (2011) Deficit and nondeficit schizophrenia: boundaries in question. Schizophr Res 130:289–290
54. Heckers S, Goff D, Schacter DL, Savage CR, Fischman AJ, Alpert NM, Rauch SL (1999) Functional imaging of memory retrieval in deficit vs nondeficit schizophrenia. Arch Gen Psychiatry 56:1117–1123
55. Buchanan RW, Breier A, Kirkpatrick B, Elkashef A, Munson RC, Gellad F, Carpenter WT Jr (1993) Structural abnormalities in deficit and nondeficit schizophrenia. Am J Psychiatry 150:59–65
56. Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase TN, Carpenter WT (1992) Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 49:522–530
57. Lahti AC, Holcomb HH, Medoff DR, Weiler MA, Tamminga CA, Carpenter WT Jr (2001) Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task. Am J Psychiatry 158:1797–1808
58. Rowland LM, Spieker EA, Francis A, Barker PB, Carpenter WT, Buchanan RW (2009) White matter alterations in deficit schizophrenia. Neuropsychopharmacology 34:1514–1522
59. Galderisi S, Quarantelli M, Volpe U, Mucci A, Cassano GB, Invernizzi G, Rossi A, Vita A, Pini S, Cassano P, Daneluzzo E, De Peri L, Stratta P, Brunetti A, Maj M (2008) Patterns of structural MRI abnormalities in deficit and nondeficit schizophrenia. Schizophr Bull 34:393–401
60. Fischer BA, Keller WR, Arango C, Pearlson GD, McMahon RP, Meyer WA, Francis A, Kirkpatrick B, Carpenter WT, Buchanan RW (2012) Cortical structural abnormalities in deficit versus nondeficit schizophrenia. Schizophr Res 136:51–54
61. Voineskos AN, Foussias G, Lerch J, Felsky D, Remington G, Rajji TK, Lobaugh N, Pollock BG, Mulsant BH (2013) Neuroimaging evidence for the deficit subtype of schizophrenia. JAMA Psychiatry 70:472–480